These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31823850)

  • 1. Comparison of antibiotic susceptibility of Escherichia coli between community-acquired and post-prostate biopsy acute bacterial prostatitis.
    Park MG; Cho MC; Cho SY; Lee JW
    Arch Esp Urol; 2019 Dec; 72(10):1018-1025. PubMed ID: 31823850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and microbiological characteristics of spontaneous acute prostatitis and transrectal prostate biopsy-related acute prostatitis: Is transrectal prostate biopsy-related acute prostatitis a distinct acute prostatitis category?
    Kim JW; Oh MM; Bae JH; Kang SH; Park HS; Moon du G
    J Infect Chemother; 2015 Jun; 21(6):434-7. PubMed ID: 25701308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
    Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
    Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Microbiological Features and Factors Associated with Fluoroquinolone Resistance in Men with Community-Acquired Acute Bacterial Prostatitis.
    Park MG; Cho MC; Cho SY; Lee JW
    Urol Int; 2016; 96(4):443-8. PubMed ID: 26943143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study.
    Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A
    Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
    Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
    Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy.
    Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H
    Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
    Song W; Choo SH; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG
    Urology; 2014 Nov; 84(5):1001-7. PubMed ID: 25443894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive culture for extended-spectrum β-lactamase during acute prostatitis after prostate biopsy is a risk factor for progression to chronic prostatitis.
    Oh MM; Chae JY; Kim JW; Kim JW; Yoon CY; Park MG; Moon du G
    Urology; 2013 Jun; 81(6):1209-12. PubMed ID: 23601450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiología, sensibilidad antibiótica y factores asociados a bacteriemia en la prostatitis aguda].
    Ferré C; Llopis F; Jacob J
    Rev Esp Quimioter; 2016 Aug; 29(4):190-4. PubMed ID: 27305509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
    Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
    Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.
    Ekici S; Cengiz M; Turan G; Alış EE
    Int Urol Nephrol; 2012 Feb; 44(1):19-27. PubMed ID: 21547465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen.
    Williamson DA; Roberts SA; Paterson DL; Sidjabat H; Silvey A; Masters J; Rice M; Freeman JT
    Clin Infect Dis; 2012 May; 54(10):1406-12. PubMed ID: 22419681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis.
    Shigehara K; Miyagi T; Nakashima T; Shimamura M
    J Infect Chemother; 2008 Feb; 14(1):40-3. PubMed ID: 18297448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
    Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y
    Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor.
    Mosharafa AA; Torky MH; El Said WM; Meshref A
    Urology; 2011 Sep; 78(3):511-4. PubMed ID: 21782225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study.
    Nakagawa R; Shigehara K; Aoyama S; Urata S; Ofude M; Miyagi T; Nakashima T; Izumi K; Mizokami A
    J Infect Chemother; 2019 May; 25(5):337-340. PubMed ID: 30718193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and significance of fluoroquinolone-resistant bacteria carriage in patients undergoing transrectal ultrasound prostate biopsy.
    Hasanzadeh A; Pourmand MR; Alizadeh A; Pourmand G
    Urol J; 2017 May; 14(3):3085-3090. PubMed ID: 28537050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of two-time prophylactic intravenous administration of tazobactam/piperacillin for transrectal ultrasound-guided needle biopsy of the prostate.
    Iwamoto H; Shigehara K; Miyagi T; Nakashima T; Shimamura M; Namiki M
    Prostate Int; 2015 Sep; 3(3):103-6. PubMed ID: 26473153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiology and Drug Resistance of Pathogens in Patients Hospitalized at the Nephrology Department in the South of Poland.
    Michno M; Sydor A; Wałaszek M; Sułowicz W
    Pol J Microbiol; 2018; 67(4):517-524. PubMed ID: 30550238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.